Lowenstein Sandler is representing long-time client, Indorama Ventures Public Company Limited, in the proposed acquisition of a Decatur, Alabama manufacturing facility from BP Amoco Chemical Company. The definitive purchase agreement for the 1,000-acre, 450-employee facility was signed on January 6, 2016. The acquisition of the Decatur facility is the sixth investment in North America in which Lowenstein represented Indorama and the second in the past year. In 2007, Lowenstein represented Indorama in acquiring the land rights and raw material supply agreement from BP to build its AlphaPet plant, which is co-located at the Decatur site. The Lowenstein team was led by partner Nicholas San Filippo IV, and included Nicholas Mehler, Christine Osvald-Mruz, Brian Silikovitz, Norman Spindel, Stuart Yusem, Sam Khan, Ethan Skerry, Lesley Pruzansky Adamo, Eugene Cheval, Robert Bee, and Meredith Jewitt.
January 6, 2016